Cellebrite Shareholders Approve CEO Pay Package

Cellebrite DI Ltd. shareholders approved CEO Shiven Ramji's pay package, re-elected directors, and re-appointed auditors at their annual meeting on September 24, 2026. 80.9% of shares were represented, per the company's SEC filing.

Original reporting
Published Sep 24, 2026, 8:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 24, 2026, 9:53 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$CLBT
Neutral
high confidence
Mentioned
$CLBT
Relevance
5/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CLBTNeutralLow
01

Why it matters

The filing confirms governance actions but does not alter the company's financial outlook.

02

Market read

A routine corporate governance update with limited trading relevance.

03

What to watch

Potential future compensation changes tied to performance milestones.

Relevance 5/10Novelty 5/10Timing: post‑meeting Sep 24 2026

Background

Cellebrite DI Ltd. filed a Form 6‑K reporting its annual general meeting outcomes.

Company-level read

Ticker impact

$CLBTNeutralHigh confidence
Context

Shareholders approved the CEO compensation package at the annual meeting.

Expected impact

Minimal price movement expected.

Evidence & confidence

Routine corporate action; market typically reacts little.

Market effects

None significant for the digital forensics sector.

Limited to Israeli‑listed companies; no broader regional effect.

Low; only relevant to CLBT shareholders.

Counterpoint

If investors view executive pay as excessive, a short‑term dip could occur.

Key entities

  • Cellebrite DI Ltd.

    Digital forensics and data extraction firm listed on Nasdaq (CLBT).

  • Shiven Ramji

    Chief Executive Officer whose compensation was approved.

Related articles

$CLBTHighAI 8/10

Cellebrite DI Ltd. (CLBT): Financial results for Q3 2026

Cellebrite DI Ltd. (CLBT) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Cellebrite Reports Third-Quarter 2026 Results Third-Quarter ARR Growth of 20% and TTM Free Cash Flow Margin of 31% Net income of $26.7 million; Non-GAAP net income of $45.6 million and adjusted EBITDA of $53.6 million, 36% adjusted EBITDA margin TYSONS CORNER, VA and

$CLBTHigh

Cellebrite Reports Third-Quarter 2026 Results

Cellebrite reported Q3 2026 results with ARR up 20% to $528.5M, revenue up 18% to $149M, and adjusted EBITDA of $53.6M. CEO Shiv Ramji highlighted strong international and U.S. Federal performance, and raised 2026 adjusted EBITDA outlook to $163M-$166M. The company also announced plans to redomicile in the U.S. and progress with its Genesis AI solution.

$CLBTMedAI 8/10

Cellebrite (CLBT) Q2 2026 Earnings Call Transcript

Cellebrite (CLBT) announced Shiv Ramji as its new CEO, replacing Tom Hogan. The company missed Q2 revenue expectations due to delayed large transactions and lower-than-expected ARR uplift. Despite this, they raised their full-year adjusted EBITDA target. Ramji outlined plans to improve sales execution and forecasting discipline. The company sees growth in new products and federal business, with a 25% increase in Defense and Intelligence ARR.